Challenges of infectious diseases in the USA

被引:78
|
作者
Khabbaz, Rima F. [1 ]
Moseley, Robin R. [1 ]
Steiner, Riley J. [2 ]
Levitt, Alexandra M. [1 ]
Bell, Beth P. [3 ]
机构
[1] Ctr Dis Control & Prevent, Off Infect Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA
来源
LANCET | 2014年 / 384卷 / 9937期
关键词
SEXUALLY-TRANSMITTED INFECTIONS; CARE-ASSOCIATED INFECTIONS; BLOOD-STREAM INFECTIONS; MOUNTAIN-SPOTTED-FEVER; NILE-VIRUS-INFECTION; CHRONIC HEPATITIS-C; UNITED-STATES; ACTIVE SURVEILLANCE; HIV PREVENTION; PERSONS BORN;
D O I
10.1016/S0140-6736(14)60890-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the USA, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. Additional concerns include health-care-associated and foodborne infections-both of which have been targets of broad prevention efforts, with success in some areas, yet major challenges remain. Although substantial progress in reduction of the burden of vaccine-preventable diseases has been made, continued cases and outbreaks of these diseases persist, driven by various contributing factors. Worldwide, emerging and reemerging infections continue to challenge prevention and control strategies while the growing problem of antimicrobial resistance needs urgent action. An important priority for control of infectious disease is to ensure that scientific and technological advances in molecular diagnostics and bioinformatics are well integrated into public health. Broad and diverse partnerships across governments, health care, academia, and industry, and with the public, are essential to effectively reduce the burden of infectious diseases.
引用
下载
收藏
页码:53 / 63
页数:11
相关论文
共 50 条
  • [21] Meeting the challenges in clinical microbiology and infectious diseases
    Finch, R
    Beeching, N
    Phillips, I
    CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (08) : 401 - 401
  • [22] Challenges in mucosal vaccines for the control of infectious diseases
    Azegami, Tatsuhiko
    Yuki, Yoshikazu
    Kiyono, Hiroshi
    INTERNATIONAL IMMUNOLOGY, 2014, 26 (09) : 517 - 528
  • [23] Opportunities and challenges in modeling emerging infectious diseases
    Metcalf, C. Jessica E.
    Lessler, Justin
    SCIENCE, 2017, 357 (6347) : 149 - 152
  • [24] The ASID test The Australasian Society for Infectious Diseases view on infectious diseases challenges in 2016 and beyond
    Jones, Cheryl A.
    Davis, Joshua S.
    Looke, David F. M.
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (07) : 250 - +
  • [25] Dearth of infectious diseases physicians as the USA faces a global pandemic
    Hussaini, Syed M. Qasim
    LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 648 - 649
  • [26] Infectious Diseases Subspecialty: Declining Demand Challenges and Opportunities
    Chandrasekar, Pranatharthi
    Havlichek, Daniel
    Johnson, Leonard B.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (11) : 1593 - 1598
  • [27] Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
    Nii-Trebi, Nicholas Israel
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017 : 1 - 15
  • [28] Biobanking in LMIC settings for infectious diseases: Challenges and enablers
    Ezzat, Sameera
    Biga, Ruzica
    Kozlakidis, Zisis
    BIOSAFETY AND HEALTH, 2022, 4 (05) : 290 - 292
  • [29] Diagnostic Challenges and Opportunities in Older Adults With Infectious Diseases
    van Duin, David
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (07) : 973 - 978
  • [30] New Opportunities to Meet the Grand Challenges in Infectious Diseases
    Liang, Chen
    FRONTIERS IN GENOME EDITING, 2020, 2